Risk stratification and long-term outcome of patients receiving in-hospital medical emergency team critical care: experience from Austria's largest medical center.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 14 6 2023
pubmed: 19 10 2022
entrez: 18 10 2022
Statut: ppublish

Résumé

We aimed to investigate predictors for long-term survival of in-hospital patients with medical emergency team (MET) consultation with or without in-hospital cardiac arrest (IHCA) in Austria's largest medical center. Data of patients, who needed an intervention of a MET between 01/2014 and 03/2020 were reviewed for this retrospective analysis. In total, 708 MET calls were analyzed. The minimum follow-up was 7 months, the maximum 6.2 years. The main MET indications were circulatory failure (63%) followed by respiratory failure (27.1%), and bleeding events (3.5%). IHCA with subsequent cardiopulmonary resuscitation (CPR) was experienced by 425 (60%) patients. Of those, 274 (64%) reached return of spontaneous circulation (ROSC), and 221 (52%) survived the first 24-hours (median survival: 146 days) and 22.1% the first year. After adjustment for potential confounders, age (P<0.001), time to ROSC (P<0.001), a non-shockable rhythm (P=0.041), chronic kidney disease (CKD, P=0.041), peak lactate levels (P<0.001), and C-reactive protein (P=0.001) were associated with long-term all-cause mortality in IHCA patients in Cox regression analysis. The 283 MET calls (40%) which were due to other reasons than IHCA were associated with a much better 24-hours (93%) and 1-year survival (61.8%). Beside age (P<0.001), the main risk factors associated with mortality in MET patients without IHCA were comorbidities such as chronic obstructive pulmonary disease (COPD, P=0.008), CKD (P=0.001), pulmonary hypertension/chronic thromboembolic pulmonary hypertension (PH/CTEPH, P=0.024), and cancer (P=0.040). Patients triggering MET calls have an increased mortality, especially those with IHCA. Predictors of mortality comprise age, comorbidities, and cardiac arrest-related parameters. A better characterization of MET call populations and their outcome might help to improve clinical decision making.

Sections du résumé

BACKGROUND BACKGROUND
We aimed to investigate predictors for long-term survival of in-hospital patients with medical emergency team (MET) consultation with or without in-hospital cardiac arrest (IHCA) in Austria's largest medical center.
METHODS METHODS
Data of patients, who needed an intervention of a MET between 01/2014 and 03/2020 were reviewed for this retrospective analysis.
RESULTS RESULTS
In total, 708 MET calls were analyzed. The minimum follow-up was 7 months, the maximum 6.2 years. The main MET indications were circulatory failure (63%) followed by respiratory failure (27.1%), and bleeding events (3.5%). IHCA with subsequent cardiopulmonary resuscitation (CPR) was experienced by 425 (60%) patients. Of those, 274 (64%) reached return of spontaneous circulation (ROSC), and 221 (52%) survived the first 24-hours (median survival: 146 days) and 22.1% the first year. After adjustment for potential confounders, age (P<0.001), time to ROSC (P<0.001), a non-shockable rhythm (P=0.041), chronic kidney disease (CKD, P=0.041), peak lactate levels (P<0.001), and C-reactive protein (P=0.001) were associated with long-term all-cause mortality in IHCA patients in Cox regression analysis. The 283 MET calls (40%) which were due to other reasons than IHCA were associated with a much better 24-hours (93%) and 1-year survival (61.8%). Beside age (P<0.001), the main risk factors associated with mortality in MET patients without IHCA were comorbidities such as chronic obstructive pulmonary disease (COPD, P=0.008), CKD (P=0.001), pulmonary hypertension/chronic thromboembolic pulmonary hypertension (PH/CTEPH, P=0.024), and cancer (P=0.040).
CONCLUSIONS CONCLUSIONS
Patients triggering MET calls have an increased mortality, especially those with IHCA. Predictors of mortality comprise age, comorbidities, and cardiac arrest-related parameters. A better characterization of MET call populations and their outcome might help to improve clinical decision making.

Identifiants

pubmed: 36255709
pii: S0026-4806.22.07780-1
doi: 10.23736/S0026-4806.22.07780-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-315

Auteurs

Safoura Sheikh Rezaei (S)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Constantin Gatterer (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Patrick Sulzgruber (P)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Felix Hofer (F)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Helene Mittlboeck (H)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Stefan Gavrilovic (S)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Yannick Loyoddin (Y)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Michael Wolzt (M)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Robert Schönbauer (R)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Walter Speidl (W)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Bernhard Richter (B)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Gottfried Heinz (G)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria - gottfried.heinz@meduniwien.ac.at.

Michael Sponder (M)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH